mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |